Rifaximin for maintenance therapy in antibiotic-dependent pouchitis

BMC Gastroenterology

Volumn 8, Issue , 2008, Pages

  Shen, Bo ^a   Remzi, Feza H ^a   Lopez, A Rocio ^a   Queener, Elaine ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAXIMIN; TINIDAZOLE; ANTIINFECTIVE AGENT; RIFAMYCIN;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLON RESECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FACE RASH; FEMALE; HUMAN; ILEITIS; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OPEN STUDY; PATIENT COMPLIANCE; REMISSION; SCORING SYSTEM; TREATMENT DURATION; ULCERATIVE COLITIS; ANTIBIOTIC RESISTANCE; PROCTOCOLECTOMY; RECURRENT DISEASE;

ADULT; ANTI-BACTERIAL AGENTS; COHORT STUDIES; COLITIS, ULCERATIVE; DRUG RESISTANCE, MICROBIAL; HUMANS; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; RECURRENCE; REMISSION INDUCTION; RIFAMYCINS;

EID: 47349133369     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-8-26     Document Type: Article

References (24)

1. Pardi DS Sandborn WJ Systematic review: The management of pouchitis Aliment Pharmacol Ther 2006, 23:1087-96 10.1111/j.1365-2036.2006.02884.x 16611268
2. Shen B Fazio VW Remzi FH Lashner BA Clinical approach to diseases of ileal pouch-anal anastomosis Am J Gastroenterol 2005, 100:2796-807 10.1111/j.1572-0241.2005.00278.x 16393238
3. Cheifetz A Itzkowitz S The diagnosis and treatment of pouchitis in inflammatory bowel disease J Clin Gastroenterol 2004, 38(Suppl 1):S44-50 10.1097/01.mcg.0000124001.93146.ef
4. Lovegrove RE Tilney HS Heriot AG et al. A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis Dis Colon Rectum 2006, 49:1293-1306 10.1007/s10350-006-0608-0 16830218
5. Simchuk EJ Thirlby RC Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses World J Surg 2000, 24:851-856 10.1007/s002680010136 10833254
6. Gionchetti P Rizzello F Venturi A et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis Aliment Pharmacol Ther 1999, 13:713-718 10.1046/j.1365-2036.1999.00553.x 10383499
7. Mahadevan U Sandborn WJ Diagnosis and management of pouchitis Gastroenterology 2003, 124:1636-1650 10.1016/S0016-5085(03)00325-1 12761722
8. Meagher AP Farouk R Dozois RR Kelly KA Pemberton JH J ileal pouch-anal anastomosis for chronic ulcerative colitis: Complications and long-term outcome in 1310 patients Br J Surg 1998, 85:800-803 10.1046/ j.1365-2168.1998.00689.x 9667712
9. Lohmuller JL Pemberton JH Dozois RR Ilstrup D van Heerden J Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis Ann Surg 1990, 211:622-627 discussion 627-629 1358238 2339922
10. Hurst RD Molinari M Chung TP Rubin M Michelassi F Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy Arch Surg 1996, 131:497-500 discussion 501-502 8624195
11. Shen B Brzezinski A Fazio VW et al Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: Experience in clinical practice Aliment Pharmacol Ther 2005, 22:721-728 10.1111/j.1365-2036.2005.02642.x 16197493
12. Madden MV McIntyre AS Nicholls RJ Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis Dig Dis Sci 1994, 39:1193-1196 10.1007/BF02093783 8200250
13. Mimura T Rizzello F Helwig U et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis Aliment Pharmacol Ther 2002, 16:909-917 10.1046/ j.1365-2036.2002.01203.x 11966499
14. Koo HL DuPont HL Current and future developments in travelers' diarrhea therapy Expert Rev Anti Infect Ther 2006, 4:417-427 10.1586/ 14787210.4.3.417 16771619
15. Scarpignato C Pelosini I Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic Digestion 2006, 73(Suppl 1):13-27 10.1159/000089776 16498249
16. Abdelrazeq AS Kelly SM Lund JN Leveson SH Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis Colorectal Dis 2005, 7:182-186 10.1111/j.1463-1318.2004.00746.x 15720360
17. Baidoo L Kundu R Su C et al. Rifaximin is an effective antibiotic for the treatment of pouchitis [abstract] Gastroenterology 2005, 128(4 Suppl 2):A797
18. Kornbluth A Hunt M George J Legnani P An open label pilot trial of rifaximin in the treatment of patients with refractory pouchitis [abstract] Gastroenterology 2006, 130(4 Suppl 2):A658
19. Shen B Achkar JP Connor JT et al. Modified pouchitis disease activity index: A simplified approach to the diagnosis of pouchitis Dis Colon Rectum 2003, 46:748-753 10.1007/s10350-004-6652-8 12794576
20. Sandborn WJ Tremaine WJ Batts KP Pemberton JH Phillips SF Pouchitis after ileal pouch-anal anastomosis: A Pouchitis Disease Activity Index Mayo Clin Proc 1994, 69:409-415 8170189
21. Gionchetti P Rizzello F Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial Gastroenterology 2000, 119:305-309 10.1053/gast.2000.9370 10930365
22. Mimura T Rizzello F Helwig U et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis Gut 2004, 53:108-14 1773918 14684584 10.1136/gut.53.1.108
23. Isaacs KL Sandler RS Abreu M et al. Crohn's and Colitis Foundation of America Clinical Alliance. Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study Inflamm Bowel Dis 2007, 13:1250-1255 10.1002/ibd.20187 17567869
24. DuPont HL Jiang ZD Okhuysen PC et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea Ann Intern Med 2005, 142:805-812 15897530